Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity, suitable for leukemia research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $115 | In Stock | |
5 mg | $286 | In Stock | |
10 mg | $392 | In Stock | |
25 mg | $643 | In Stock | |
50 mg | $987 | In Stock | |
100 mg | $1,460 | In Stock | |
200 mg | $1,970 | In Stock |
Description | Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity, suitable for leukemia research. |
In vitro | Zifomenib acts highly selective in MLL-r and NPM1mut acute myeloid leukemia and synergizes with a variety of targeted drugs in vitro[1]. |
Alias | KO-539 |
Molecular Weight | 717.871 |
Formula | C33H42F3N9O2S2 |
Cas No. | 2134675-36-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (111.44 mM), Sonification is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.